Avilex Pharma
Copenhagen
About Avilex Pharma
Avilex Pharma is a spin out from the University of Copenhagen, founded by Professor Kristian Strømgaard and Assis. Prof. Anders Bach of the Department of Drug Design and Pharmacology, with investment from Novo Seeds (part of Novo A/S) and Wellcome Trust.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Last round: Series Unknown (Feb 2013)
- Website: avilexpharma.com
Industries & Categories
Biotechnology, Health Care, Medical
Social Profiles
Canonical: https://fsome.com/organization/avilex-pharma-2892065 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.